E-cadherin expression and bromodeoxyuridine incorporation during development of ovarian inclusion cysts in age-matched breeder and incessantly ovulated CD-1 mice

Reproductive Biology and Endocrinology

Volumn 5, Issue , 2007, Pages

  Fleming, Jean S ^a   McQuillan, H James ^b   Millier, Melanie J ^b   Beaugié, Clare R ^b   Livingstone, Vicki ^c  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; BROXURIDINE; ESTRADIOL; TESTOSTERONE; UVOMORULIN; CADHERIN;

ANDROSTENEDIONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CILIATED EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCESSANT OVULATION; MOUSE; NONHUMAN; OVARY CYST; OVULATION; PROTEIN EXPRESSION; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL; AGING; ANIMAL; BLOOD; BREEDING; CYST FLUID; EPITHELIUM; IMMUNOCHEMISTRY; METABOLISM; MOUSE STRAIN; OSMOLARITY; OVARY; PATHOLOGY; PATHOPHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALIA; MUS;

AGING; ANDROSTENEDIONE; ANIMALS; APOPTOSIS; BREEDING; BROMODEOXYURIDINE; CADHERINS; CYST FLUID; EPITHELIUM; ESTRADIOL; FEMALE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MICE; MICE, INBRED STRAINS; OSMOLAR CONCENTRATION; OVARIAN CYSTS; OVARY; OVULATION; SPECIES SPECIFICITY; TESTOSTERONE;

EID: 34247526796     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-5-14     Document Type: Article

References (47)

1. Clow OL Hurst PR Fleming JS Changes in the mouse ovarian surface epithelium with age and ovulation number Mol Cell Endocrinol 2002 191 1 105-111 10.1016/S0303-7207(02)00061-8 12044924
2. Tan OL Hurst PR Fleming JS Location of inclusion cysts in mouse ovaries in relation to age, pregnancy and total ovulation number: Implications for ovarian cancer? J Pathol 2005 205 483-490 10.1002/path.1719 15685692
3. Faleiro-Rodrigues C Macedo-Pinto I Pereira D Ferreira VM Lopes CS Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas Hum Pathol 2004 35 6 663-669 10.1016/j.humpath.2004.01.024 15188131
4. Lombaerts M van Wezel T Philippo K Dierssen JW Zimmerman RM Oosting J van Eijk R Eilers PH van de Water B Cornelisse CJ Cleton-Jansen AM E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines Br J Cancer 2006 94 5 661-671 16495925
5. Salon C Lantuejoul S Eymin B Gazzeri S Brambilla C Brambilla E The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis Fut Oncol 2005 1 5 649-660 10.2217/ 14796694.1.5.649 16556042
6. Guilford P Hopkins J Harraway J McLeod M McLeod N Harawira P Taite H Scoular R Miller A Reeve AE E-cadherin germline mutations in familial gastric cancer Nature 1998 392 6674 402-405 10.1038/32918 9537325
7. Scully RE Pathology of ovarian cancer precursors J Cell Biochem Suppl 1995 23 208-218 10.1002/jcb.240590928 8747398
8. Zhang XY Pettengell R Nasiri N Kalia V Dalgleish AG Barton DP Characteristics and growth patterns of human peritoneal mesothelial cells: Comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources J Soc Gynecol Investig 1999 6 6 333-340 10.1016/S1071-5576(99)00040-4 10643588
9. Maines Bandiera SL Auersperg N Increased E-cadherin expression in ovarian surface epithelium: An early step in metaplasia and dysplasia? Int J Gynecol Pathol 1997 16 3 250-255 9421091
10. Davies BR Worsley SD Ponder BA Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers Histopathology 1998 32 1 69-80 10.1046/ j.1365-2559.1998.00341.x 9522220
11. Auersperg N Pan J Grove BD Peterson T Fisher J Maines Bandiera S Somasiri A Roskelley CD E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium Proc Natl Acad Sci USA 1999 96 11 6249-6254 26867 10339573 10.1073/pnas.96.11.6249
12. Darai E Leblanc M Walkercombrouze F Bringuier AF Madelenat P Scoazec JY Expression of cadherins and CD44 isoforms in ovarian endometrial cysts Hum Reprod 1998 13 5 1346-1352 10.1093/humrep/13.5.1346 9647570
13. Woolnough E Russo L Khan MS Heatley MK An immunohistochemical study of the rete ovarii and epoophoron Pathology 2000 32 2 77-83 10.1080/ 003130200104277 10840824
14. Mackay S Nicholson CL Lewis SP Brittan M E-cadherin in the developing mouse gonad Anat Embryol (Berl) 1999 200 1 91-102 10.1007/s004290050263 10395010
15. Blaustein A Surface (germinal) epithelium and related ovarian neoplasms Pathol Ann 1981 16 Pt 1 247-294
16. Whittington K Assinder SJ Parkinson T Lapwood KR Nicholson HD Function and localization of oxytocin receptors in the reproductive tissue of rams Reproduction 2001 122 2 317-325 10.1530/rep.0.1220317 11467983
17. Gold EJ Zhang X Wheatley AM Mellor SL Cranfield M Risbridger GP Groome NP Fleming JS betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration J Mol Endocrinol 2005 34 2 505-515 10.1677/jme.1.01657 15821113
18. Jha RK Titus S Saxena D Kumar PG Laloraya M Profiling of E-cadherin, beta-catenin and Ca(2+) in embryo-uterine interactions at implantation FEBS Lett 2006 580 24 5653-5660 10.1016/j.febslet.2006.09.014 17011554
19. Long GG Apparent mesonephric duct (rete anlage) origin for cysts and proliferative epithelial lesions in the mouse ovary Toxicol Pathol 2002 30 5 592-598 10.1080/01926230290105785 12371668
20. Clark-Knowles KV Garson K Jonkers J Vanderhyden BC Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes Exp Cell Res 2007 313 1 133-145 10.1016/j.yexcr.2006.09.026 17070800
21. Chodankar R Kwang S Sangiorgi F Hong H Yen HY Deng C Pike MC Shuler CF Maxson R Dubeau L Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells Curr Biol 2005 15 6 561-565 10.1016/j.cub.2005.01.052 15797026
22. Bristol-Gould SK Hutten CG Sturgis C Kilen SM Mayo KE Woodruff TK The development of a mouse model of ovarian endosalpingiosis Endocrinology 2005 146 12 5228-5236 10.1210/en.2005-0697 16141389
23. Cho BN McMullen ML Pei L Yates CJ Mayo KE Reproductive deficiencies in transgenic mice expressing the rat inhibin alpha-subunit gene Endocrinology 2001 142 11 4994-5004 10.1210/en.142.11.4994 11606468
24. Dinulescu DM Ince TA Quade BJ Shafer SA Crowley D Jacks T Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer Nat Med 2005 11 1 63-70 10.1038/nm1173 15619626
25. Xing D Orsulic S A mouse model for the molecular characterization of brca1-associated ovarian carcinoma Cancer Res 2006 66 18 8949-8953 1802660 16982732 10.1158/0008-5472.CAN-06-1495
26. Tan OL Fleming JS Proliferating cell nuclear antigen immunoreactivity in the ovarian surface epithelium of mice of varying ages and total lifetime ovulation number following ovulation Biol Reprod 2004 71 5 1501-1507 10.1095/biolreprod.104.030460 15229142
27. Khan MS Dodson AR Heatley MK Ki-67, oestrogen receptor, and progesterone receptor proteins in the human rete ovarii and in endometriosis J Clin Pathol 1999 52 7 517-520 501494 10605405
28. Selden JR Dolbeare F Clair JH Nichols WW Miller JE Kleemeyer KM Hyland RJ DeLuca JG Statistical confirmation that immunofluorescent detection of DNA repair in human fibroblasts by measurement of bromodeoxyuridine incorporation is stoichiometric and sensitive Cytometry 1993 14 2 154-167 10.1002/cyto.990140207 8440149
29. Beisker W Hittelman WN Measurement of the kinetics of DNA repair synthesis after uv irradiation using immunochemical staining of incorporated 5-bromo-2'-deoxyuridine and flow cytometry Exp Cell Res 1988 174 1 156-167 10.1016/0014-4827(88)90151-6 3275543
30. Ivarsson K Sundfeldt K Brannstrom M Janson PO Production of steroids by human ovarian surface epithelial cells in culture: Possible role of progesterone as growth inhibitor Gynecol Oncol 2001 82 1 116-121 10.1006/ gyno.2001.6219 11426972
31. Rodriguez GC Walmer DK Cline M Krigman H Lessey BA Whitaker RS Dodge R Hughes CL Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 1998 5 5 271-276 10.1016/S1071-5576(98)00017-3 9773403
32. Murdoch WJ Van Kirk EA Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells Mol Cell Endocrinol 2002 186 1 61-67 10.1016/ S0303-7207(01)00675-X 11850122
33. Syed V Ulinski G Mok SC Yiu GK Ho SM Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells Cancer Res 2001 61 18 6768-6776 11559549
34. Konishi I Kuroda H Mandai M Review: Gonadotropins and development of ovarian cancer Oncology 1999 57 Suppl 2 45-48 10.1159/000055274 10545802
35. Parrott JA Doraiswamy V Kim G Mosher R Skinner MK Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer Mol Cell Endocrinol 2001 172 1-2 213-222 10.1016/S0303-7207(00)00340-3 11165055
36. Ivarsson K Sundfeldt K Brannstrom M Hellberg P Janson PO Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells Hum Reprod 2001 16 1 18-23 10.1093/humrep/16.1.18 11139530
37. Tashiro H Katabuchi H Begum M Li X Nitta M Ohtake H Okamura H Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines Cancer Sci 2003 94 11 953-959 10.1111/ j.1349-7006.2003.tb01384.x 14611671
38. Burdette J Kurley S Kilen S Mayo K Woodruff T Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice Endocrinology 2006 147 2338-2345 10.1210/en.2005-1629 16484319
39. Davies BR Finnigan DS Smith SK Ponder BA Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium Gynecol Endocrinol 1999 13 2 75-81 10399050
40. Nogales FF Carvia RE Donne C Campello TR Vidal M Martin A Adenomas of the rete ovarii Hum Pathol 1997 28 12 1428-1433 10.1016/ S0046-8177(97)90235-5 9416702
41. Shiohara S Shiozawa T Shimizu M Toki T Ishii K Nikaido T Fujii S Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis Cancer 1997 80 5 908-916 10.1002/ (SICI)1097-0142(19970901)80:5<908::AID-CNCR12>3.0.CO;2-# 9307191
42. Chadha S Rao BR Slotman BJ van Vroonhoven CC van der Kwast TH An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors Hum Pathol 1993 24 1 90-95 10.1016/0046-8177(93)90067-Q 8418017
43. Inoue M Ogawa H Miyata M Shiozaki H Tanizawa O Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs Am J Clin Pathol 1992 98 1 76-80 1615930
44. Sundfeldt K Piontkewitz Y Ivarsson K Nilsson O Hellberg P Brannstrom M Janson PO Enerback S Hedin L E-cadherin expression in human epithelial ovarian cancer and normal ovary Int J Cancer 1997 74 3 275-280 10.1002/ (SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W 9221804
45. Peralta Soler A Knudsen KA Tecson Miguel A McBrearty FX Han AC Salazar H Expression of E-cadherin and N-cadherin in surface epithelial- stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors Hum Pathol 1997 28 6 734-739 10.1016/S0046-8177(97)90184-2 9191009
46. Faleiro-Rodrigues C Macedo-Pinto I Pereira D Lopes CS Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas Ann Oncol 2004 15 10 1535-1542 10.1093/annonc/mdh387 15367415
47. Symonds D Tomic D Borgeest C McGee E Flaws JA Smad 3 regulates proliferation of the mouse ovarian surface epithelium Anat Rec A Discov Mol Cell Evol Biol 2003 273 2 681-686 10.1002/ar.a.10090 12845704